Radiation therapy firm North American Scientific reported fiscal second-quarter revenues of $8.1 million, down 12% compared with the $9.1 million posted in the second quarter of 2005.
For the period (end-April 30), the Chatsworth, CA-based firm had a net loss of $3.6 million, compared with a net loss of $3.9 million last year.
The revenue decrease was due to reduced intensity-modulated radiation therapy/image-guided radiation therapy (IMRT/IGRT) service revenue, NAS said.
By AuntMinnie.com staff writers
June 8, 2006
Related Reading
NAS raises $24 million, June 7, 2006
NAS inks prostate brachytherapy deal with Novation, May 18, 2006
U.S. NRC signs off on NAS brachytherapy, May 8, 2006
NAS gets FDA 510(k) for low-dose breast Brachytherapy, April 26, 2006
NAS opens $4 million credit line, March 31, 2006
Copyright © 2006 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
